These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11431187)
1. Hepatitis C screening strategies in hemodialysis patients. Saab S; Brezina M; Gitnick G; Martin P; Yee HF Am J Kidney Dis; 2001 Jul; 38(1):91-7. PubMed ID: 11431187 [TBL] [Abstract][Full Text] [Related]
2. Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis. Saab S; Martin P; Brezina M; Gitnick G; Yee HF Am J Kidney Dis; 2001 Feb; 37(2):308-15. PubMed ID: 11157371 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434 [TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis. Lemos LB; Perez RM; Matos CA; Silva IS; Silva AE; Ferraz ML J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594 [TBL] [Abstract][Full Text] [Related]
5. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385 [TBL] [Abstract][Full Text] [Related]
6. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921 [TBL] [Abstract][Full Text] [Related]
7. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052 [TBL] [Abstract][Full Text] [Related]
8. Outcome of screening for hepatitis C virus infection based on risk factors. Mallette C; Flynn MA; Promrat K Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850 [TBL] [Abstract][Full Text] [Related]
9. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study. Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533 [TBL] [Abstract][Full Text] [Related]
10. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit. Hussein MM; Mooij JM; Hegazy MS; Bamaga MS Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C infection screening in hemodialysis units. Neng Lai K Am J Kidney Dis; 2001 Jul; 38(1):186-8. PubMed ID: 11431201 [No Abstract] [Full Text] [Related]
13. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test. Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program. Lapane KL; Jakiche AF; Sugano D; Weng CS; Carey WD Am J Gastroenterol; 1998 Apr; 93(4):591-6. PubMed ID: 9576453 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811 [TBL] [Abstract][Full Text] [Related]
16. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. Furusyo N; Hayashi J; Ariyama I; Sawayama Y; Etoh Y; Shigematsu M; Kashiwagi S Am J Gastroenterol; 2000 Feb; 95(2):490-6. PubMed ID: 10685756 [TBL] [Abstract][Full Text] [Related]
17. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan. Ahmad N; Asgher M; Shafique M; Qureshi JA Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466 [TBL] [Abstract][Full Text] [Related]
18. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis. Herrine SK; Michael B; Ma WL; Rossi S; Dunn SR; Hyslop T Am J Gastroenterol; 2002 Oct; 97(10):2619-22. PubMed ID: 12385449 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients. Medhi S; Potukuchi SK; Polipalli SK; Swargiary SS; Deka P; Chaudhary A; Begum N; Hussain Z; Ahlawat RS; Kar P Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117 [TBL] [Abstract][Full Text] [Related]
20. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]